| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 171,071 | 144,674 | 152,018 | 161,359 | | Cost of Revenue | 115,326 | 103,414 | 109,087 | 112,900 | | | Gross Profit | 55,745 | 41,260 | 42,931 | 48,459 | | | Operating Expenses | | Research Development | 7,353 | 7,496 | 7,353 | 8,184 | | Selling General and Administrative | 34,212 | 32,319 | 34,139 | 35,742 | | Non Recurring | (376) | 26 | 3,208 | 3,340 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,556 | 1,419 | (1,769) | 1,193 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (200) | (265) | 1,351 | (5,752) | | Earnings Before Interest And Taxes | 14,356 | 1,154 | (418) | (4,559) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 14,356 | 1,154 | (418) | (4,559) | | Income Tax Expense | 5,826 | 4,434 | 3,352 | 2,784 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,530 | (3,280) | (3,770) | (7,343) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,530 | (3,280) | (3,770) | (7,343) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,530 | ($3,280) | ($3,770) | ($7,343) |
|
0.51% Nasdaq 
0.17 (0.77%) 
Income Statement
